Rosemary Ikram

648 total citations
19 papers, 463 citations indexed

About

Rosemary Ikram is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Rosemary Ikram has authored 19 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Rosemary Ikram's work include Urinary Tract Infections Management (5 papers), Antifungal resistance and susceptibility (4 papers) and Salmonella and Campylobacter epidemiology (3 papers). Rosemary Ikram is often cited by papers focused on Urinary Tract Infections Management (5 papers), Antifungal resistance and susceptibility (4 papers) and Salmonella and Campylobacter epidemiology (3 papers). Rosemary Ikram collaborates with scholars based in New Zealand, Malaysia and United Kingdom. Rosemary Ikram's co-authors include Stephen T. Chambers, Mona Schousboe, D. C. Heaton, Derek N.J. Hart, Paul Corwin, Eileen Merriman, Paul Mitchell, Alison Carter, Patricia Priest and G. Mark Jeffery and has published in prestigious journals such as The American Journal of Medicine, Microbiology and Journal of Hospital Infection.

In The Last Decade

Rosemary Ikram

19 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary Ikram New Zealand 14 240 190 121 43 41 19 463
S.J. Pedler United Kingdom 16 229 1.0× 221 1.2× 82 0.7× 73 1.7× 39 1.0× 32 588
G Corcoran Ireland 14 211 0.9× 125 0.7× 99 0.8× 19 0.4× 18 0.4× 40 497
Asbjørn Digranes Norway 15 315 1.3× 435 2.3× 46 0.4× 96 2.2× 60 1.5× 55 794
Özden Türel Türkiye 16 213 0.9× 191 1.0× 75 0.6× 19 0.4× 10 0.2× 56 648
A. Pallett United Kingdom 12 167 0.7× 229 1.2× 39 0.3× 82 1.9× 11 0.3× 22 544
Lynn L. Horvath United States 14 346 1.4× 299 1.6× 28 0.2× 36 0.8× 18 0.4× 19 628
I.M. Gould United Kingdom 14 317 1.3× 271 1.4× 33 0.3× 101 2.3× 21 0.5× 30 651
John C. Galbraith Canada 12 260 1.1× 192 1.0× 52 0.4× 38 0.9× 9 0.2× 17 624
Markus Hell Austria 15 288 1.2× 288 1.5× 61 0.5× 86 2.0× 24 0.6× 37 677
José Elías García‐Sánchez Spain 12 102 0.4× 211 1.1× 31 0.3× 60 1.4× 19 0.5× 40 556

Countries citing papers authored by Rosemary Ikram

Since Specialization
Citations

This map shows the geographic impact of Rosemary Ikram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Ikram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Ikram more than expected).

Fields of papers citing papers by Rosemary Ikram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Ikram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Ikram. The network helps show where Rosemary Ikram may publish in the future.

Co-authorship network of co-authors of Rosemary Ikram

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Ikram. A scholar is included among the top collaborators of Rosemary Ikram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Ikram. Rosemary Ikram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Gauld, Natalie, Irene Zeng, Rosemary Ikram, Mark Thomas, & Stephen Buetow. (2016). Treatment of uncomplicated cystitis: analysis of prescribing in New Zealand.. PubMed. 129(1437). 55–63. 4 indexed citations
3.
Gauld, Natalie, Irene Zeng, Rosemary Ikram, Mark Thomas, & Stephen Buetow. (2016). Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. International Journal of Clinical Pharmacy. 39(1). 165–172. 16 indexed citations
4.
Ikram, Rosemary, et al.. (2015). An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors. BMC Infectious Diseases. 15(1). 224–224. 43 indexed citations
5.
Khashram, Manar, et al.. (2009). Effect of TNP on the microbiology of venous leg ulcers: a pilot study. Journal of Wound Care. 18(4). 164–167. 18 indexed citations
6.
Baker, Michael G., et al.. (2006). Regulation of chicken contamination is urgently needed to control New Zealand's serious campylobacteriosis epidemic.. PubMed. 119(1243). U2264–U2264. 41 indexed citations
7.
Mangin, Dee, et al.. (2005). Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?. PubMed. 118(1225). U1726–U1726. 9 indexed citations
8.
Merriman, Eileen, Paul Corwin, & Rosemary Ikram. (2002). Toys are a potential source of cross-infection in general practitioners' waiting rooms.. PubMed. 52(475). 138–40. 37 indexed citations
9.
Toop, Les, et al.. (2002). Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories.. PubMed. 115(1146). 12–4. 21 indexed citations
10.
Schmid, Jan, Paul Hunter, Richard D. Cannon, et al.. (1999). Evidence for a general-purpose genotype in Candida albicans , highly prevalent in multiple geographical regions, patient types and types of infection. Microbiology. 145(9). 2405–2413. 58 indexed citations
11.
Lang, S. D. R., et al.. (1999). Antibiotic susceptibility of Streptococcus pneumoniae in New Zealand.. PubMed. 112(1083). 74–8. 4 indexed citations
12.
Withington, Stephen G, Stephen T. Chambers, M. E. J. Beard, et al.. (1998). Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration. Journal of Hospital Infection. 38(1). 11–18. 24 indexed citations
13.
Ikram, Rosemary, et al.. (1994). A case control study to determine risk factors for campylobacter infection in Christchurch in the summer of 1992-3.. PubMed. 107(988). 430–2. 56 indexed citations
14.
Ikram, Rosemary, et al.. (1993). A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. Journal of Hospital Infection. 25(1). 7–14. 15 indexed citations
15.
Jeffery, G. Mark, Michael Beard, Rosemary Ikram, et al.. (1991). Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. The American Journal of Medicine. 90(1). 685–692. 26 indexed citations
16.
Jardine, David L., et al.. (1991). Epstein-Barr Virus Infection Acquired from a Cadaveric Renal Transplant. ˜The œNephron journals/Nephron journals. 58(3). 359–361. 3 indexed citations
17.
Jeffery, G. Mark, Michael Beard, Rosemary Ikram, et al.. (1991). Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. The American Journal of Medicine. 90(6). 685–692. 56 indexed citations
18.
Ikram, Rosemary, et al.. (1984). Malaria in christchurch. Pathology. 16(4). 431–433. 1 indexed citations
19.
Florkowski, Christopher M, et al.. (1984). Campylobacter jejuni myocarditis. Clinical Cardiology. 7(10). 558–559. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.J. Pedler Breakdown of academic impact, for papers by G Corcoran Breakdown of academic impact, for papers by Asbjørn Digranes Breakdown of academic impact, for papers by Özden Türel Breakdown of academic impact, for papers by A. Pallett Breakdown of academic impact, for papers by Lynn L. Horvath Breakdown of academic impact, for papers by I.M. Gould Breakdown of academic impact, for papers by John C. Galbraith Breakdown of academic impact, for papers by Markus Hell Breakdown of academic impact, for papers by José Elías García‐Sánchez
Rankless by CCL
2026